Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.

Remy SchwarzerD KivaranovicMattias MandorferR PaternostroD WolrabB HeinischThomas ReibergerM FerlitschC GernerM TraunerM Peck-RadosavljevicArnulf Ferlitsch

Published in: Alimentary pharmacology & therapeutics (2017)

Taurine is safe and may reduce portal pressure in cirrhotic patients. More studies on the underlying mechanisms of action and long-term effects of taurine supplementation are warranted.

Keyphrases

end stage renal disease
double blind
clinical trial
blood pressure
newly diagnosed
chronic kidney disease
peritoneal dialysis
open label
study protocol
patient reported outcomes
patient reported